Division Chair | Professor of HSR | Robert D. and Patricia E. Kern Scientific Director for Surgical Outcomes | Mayo Clinic; Tweets/RT /= endorsements. she/her
Rochester, MN
Joined February 2015
- Tweets301
- Following437
- Followers540
- Likes1.4K
Liz Habermann, PhD MPH retweeted
Our metastatic pancreas trial is officially open! clinicaltrials.gov/study/NCT…
Liz Habermann, PhD MPH retweeted
Hot off the press! #ASC2023 @MayoClinicSurg @MayoClinicEndo @OncoThor @EBHabermann @JSurgRes @NANETS1 @AAES @AcademicSurgery
Ethanol Ablation for Benign Insulinoma: Intraoperative and Endoscopic Approaches - Journal of Surgical Research journalofsurgicalresearch.co…
Liz Habermann, PhD MPH retweeted
I nominated myself for the Basic and Translational Science Committee at the Association for Academic Surgery aasurg.org/view/basic-transl… #ElectMyAAS via @AcademicSurgery
Liz Habermann, PhD MPH retweeted
Calling all #WomeninCancerSurgery! 💪 Don't miss our upcoming webinar on ergonomics tailored just for you! Learn practical tips to optimize comfort & performance in the operating room. Register now & elevate your surgical practice! #Ergonomics @SocSurgErgo ow.ly/gunu50Pssr1
Liz Habermann, PhD MPH retweeted
In this featured article from the @AnnSurgOncol, the authors describe their 20-year institutional experience with cytoreductive hepatectomy in over 500 patients with neuroendocrine tumor liver metastases.
Read the full article at ow.ly/VVIO50PizXh
Liz Habermann, PhD MPH retweeted
The influence of operating room 🏥 temperature 🤒 and humidity on surgical site infection 🗣️🥼🔪! @SWexner @juliomayol @PipeCabreraV @Cirbosque @pferrada1 @NeilFlochMD @TomVargheseJr @drdevirgilio @RicardoRGlz @DissanaikeMD @rbarbosa91 Link: americanjournalofsurgery.com…
Liz Habermann, PhD MPH retweeted
Disparities in Parathyroidectomy: Who Receives Appropriate Treatment f... sciencedirect.com/science/ar…
@EBHabermann @benzon_dy @MayoClinicEndo @MayoClinicSurg
Liz Habermann, PhD MPH retweeted
Survival and Symptomatic Relief After #Cytoreductive #Hepatectomy for #Neuroendocrine Tumor #LiverMetastases: Long-Term Follow-up Evaluation of More Than 500 Patients @HallberaG @Seanpcleary @MayoClinic rdcu.be/dfdTf #VisualAbstract
Liz Habermann, PhD MPH retweeted
13 talks and 5 posters (with manuscripts to come), a new role as assistant professor of HSR, my research year was certainly busy and filled with adventure. I am grateful for @ThielsCA, @EBHabermann, @MathurAmitK, @MCNguyenMD, friends, & family for their support. Off to grade 24!
Liz Habermann, PhD MPH retweeted
Join @brianjlinder at #AUA23:
High consistency OR teams during major urologic surgery associated with:
⬇️Time to 1st incision
⬇️Turnover time
⬇️Odds of prolonged hospitalization (minimally invasive nephrectomies)
@SBoorjian @MattTollefsonMD @EBHabermann
#URO @AmerUrological
Liz Habermann, PhD MPH retweeted
Invited commentary on “Hepatopancreaticobiliary cancer outcomes are associated with county-level duration of poverty”: Persistent poverty and the hepatopancreaticobiliary cancer patient: A call for multilevel structural interventions surgjournal.com/article/S003… Superb #SoMe4HBP insights from @EBHabermann @MayoClinic in @SurgJournal
Liz Habermann, PhD MPH retweeted
Thanks to @MayoClinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery for being an #ARM23 supporter.
Liz Habermann, PhD MPH retweeted
I am thrilled to see our research project was chosen as a featured article! @MayoClinicEndo @MayoClinicSurg @MayoCancerCare @IrinaBancos @EBHabermann
Informing therapeutic lymphadenectomy: Location of regional metastatic lymph nodes in adrenocortical carcinoma 🔑⤵️ ♋️☎️🪢 💥💣! #SoMe4Surgery @pferrada1 @SWexner @juliomayol @PipeCabreraV @Cirbosque @TomVargheseJr @herbchen Link: americanjournalofsurgery.com…
Liz Habermann, PhD MPH retweeted
New Today: VTE risk after #colorectal surgery for #cancer may extend to 90 days postoperatively and be increased by operation performed and operative extent.
ow.ly/fLkv50Mltin
@NPMcKenna @MayoClinic @EBHabermann
Liz Habermann, PhD MPH retweeted
Excellent choice for @Creighton and congratulations to you, Dr. @wbalrefaie || Waddah Al-Refaie, MD, FACS Named Chair of Surgery in Omaha creighton.edu/news/al-refaie…
Liz Habermann, PhD MPH retweeted
Our most recent study about sporadic vs MEN-1 insulinoma. Presented @WesternWsa @MayoClinicEndo @MayoClinicSurg @benzon_dy @tszaboyamashita @EBHabermann @OncoThor @Neuroendocrine @NANETS1
This is one of the largest cohorts to evaluate sporadic vs MEN-1 benign and malignant #insulinoma and find differences between them.
ow.ly/KvWq50LuzeT
@AAbdusada @OncoThor @MayoClinicSurg @MayoClinicEndo @MayoCancerCare
Liz Habermann, PhD MPH retweeted
Join @Univerisy @UMRochester & @MayoClinic for the fall series of Kern Center Connects on Tuesday, Sept 20 titled Diversity Science: Exploring Projects, Concepts, & Structure with Renaldo C. Blocker, Ph.D. &Ajay Jayakumar.
Register 👉 lnkd.in/eXw-ZXmU
#MayoRISEForEquity
Liz Habermann, PhD MPH retweeted
@MayoClinic Division Chair of #Epidemiology position 👇🏾 We are a candy store for collaboration! Consider joining us… please share with potential candidates.
#AcademicTwitter
#AcademicChatter
